Kalaris Therapeutics, Inc. Financial Flexibility Index
Kalaris Therapeutics, Inc. financial flexibility index. Kalaris Therapeutics, Inc. (KLRS) has a Financial Flexibility Index of -0.32x as of March 2026. Free cash flow of $-13.35 Million (operating CF $-13.35 Million minus capex $0.00) represents 0% of total liabilities ($41.25 Million). See Kalaris Therapeutics, Inc. free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Kalaris Therapeutics, Inc. (2018–2025)
Financial flexibility index of Kalaris Therapeutics, Inc. from 2018 to 2025. Historical Financial Flexibility Index trend for Kalaris Therapeutics, Inc. across 8 annual periods. Explore Kalaris Therapeutics, Inc. (KLRS) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Kalaris Therapeutics, Inc. Financial Flexibility Index by Year (2018–2025)
Kalaris Therapeutics, Inc. financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Kalaris Therapeutics, Inc.. For the full cash flow conversion analysis, see KLRS cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | $-42.78 Million | $-42.98 Million | $42.92 Million | ▲ +92.3% |
| 2024 | -12.92x | $-67.70 Million | $-67.70 Million | $5.24 Million | ▼ -4321.5% |
| 2023 | -0.29x | $-14.13 Million | $-14.13 Million | $48.35 Million | ▼ -2.1% |
| 2022 | -0.29x | $-9.78 Million | $-9.78 Million | $34.17 Million | ▲ +83.5% |
| 2021 | -1.73x | $-106.29 Million | $-106.32 Million | $61.33 Million | ▲ +49.2% |
| 2020 | -3.41x | $-60.58 Million | $-60.81 Million | $17.76 Million | ▼ -206.4% |
| 2019 | -1.11x | $-19.82 Million | $-20.16 Million | $17.80 Million | ▼ -314.1% |
| 2018 | 0.52x | $1.94 Million | $1.94 Million | $3.74 Million | — |